Trials / Completed
CompletedNCT00567385
Liquid Somatropin Formulation in Children With Growth Hormone Deficiency
An Open, Multi-centre Trial Evaluating Acceptance of the New Liquid Growth Hormone Formulation - Norditropin® SimpleXx® in Children With GH Deficiency
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 176 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 3 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
This trial is conducted in Europe. The aim of this trial is to evaluate the acceptance of the new liquid growth hormone formulation, somatropin, in children with growth hormone deficiency.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | somatropin |
Timeline
- Start date
- 2003-03-10
- Primary completion
- 2004-03-22
- Completion
- 2004-03-22
- First posted
- 2007-12-04
- Last updated
- 2017-02-28
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT00567385. Inclusion in this directory is not an endorsement.